Dr. Deborah M. Stephens
Claim this profileHuntsman Cancer Institute/University of Utah
Studies Chronic Lymphocytic Leukemia
Studies Lymphoma
11 reported clinical trials
22 drugs studied
Area of expertise
1Chronic Lymphocytic Leukemia
CD5 positive
CD19 positive
13q positive
2Lymphoma
CD5 positive
CD19 positive
13q positive
Affiliated Hospitals
Clinical Trials Deborah M. Stephens is currently running
Pneumonia Vaccines
for CLL
This phase II trial tests whether the pneumococcal pneumonia vaccine series (PCV20 and PPSV23) works to mount an effective immune response in patients with chronic lymphocytic leukemia. PCV20 and PPSV23 are both vaccines that protect against bacteria that cause pneumococcal disease. Giving these vaccinations as series may make a stronger immune response and prevent against pneumococcal infections in patients with chronic lymphocytic leukemia.
Recruiting1 award Phase 25 criteria
JCAR017
for Chronic Leukemia or Lymphoma
This trial tests JCAR017, a therapy using modified immune cells, in adults with hard-to-treat CLL or SLL. It aims to see if these enhanced immune cells can better fight the cancer.
Recruiting1 award Phase 1 & 2
More about Deborah M. Stephens
Clinical Trial Related6 years of experience running clinical trials · Led 11 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Deborah M. Stephens has experience with
- Venetoclax
- Obinutuzumab
- Ibrutinib
- Lenalidomide
- Rituximab
- JCAR017 (lisocabtagene Maraleucel)
Breakdown of trials Deborah M. Stephens has run
Chronic Lymphocytic Leukemia
Lymphoma
Non-Hodgkin's Lymphoma
Follicular Lymphoma
Chronic B-Cell Leukemia
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Deborah M. Stephens specialize in?
Deborah M. Stephens focuses on Chronic Lymphocytic Leukemia and Lymphoma. In particular, much of their work with Chronic Lymphocytic Leukemia has involved CD5 positive patients, or patients who are CD19 positive.
Is Deborah M. Stephens currently recruiting for clinical trials?
Yes, Deborah M. Stephens is currently recruiting for 4 clinical trials in Salt Lake City Utah. If you're interested in participating, you should apply.
Are there any treatments that Deborah M. Stephens has studied deeply?
Yes, Deborah M. Stephens has studied treatments such as Venetoclax, Obinutuzumab, Ibrutinib.
What is the best way to schedule an appointment with Deborah M. Stephens?
Apply for one of the trials that Deborah M. Stephens is conducting.
What is the office address of Deborah M. Stephens?
The office of Deborah M. Stephens is located at: Huntsman Cancer Institute/University of Utah, Salt Lake City, Utah 84112 United States. This is the address for their practice at the Huntsman Cancer Institute/University of Utah.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.